INMD
Undervalued by 119.2% based on the discounted cash flow analysis.
Market cap | $1.02 Billion |
---|---|
Enterprise Value | $895.23 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $2.29 |
Beta | 2.02 |
Outstanding Shares | 68,760,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 5.73 |
---|---|
PEG | -24.73 |
Price to Sales | 2.87 |
Price to Book Ratio | 1.59 |
Enterprise Value to Revenue | 2.39 |
Enterprise Value to EBIT | 8.12 |
Enterprise Value to Net Income | 7 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.03 |
No data
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...